邯郸白带红是什么原因邯郸突然月经量少,邯郸确定怀孕后做什么检查,邯郸马丽亚医院看乳腺,邯郸怀孕一个月腹痛正常吗,邯郸怎样能去腋臭,邯郸盆腔积液会自己好吗,邯郸白带多而且稠怎么回事

CANBERRA, Sept. 6 (Xinhua) -- A rare virus that can be contracted by humans has killed a large number of Victorian pigeons after being detected in the Australian state for the first time, Agriculture Department confirmed on Tuesday.According to the Australian Chief Veterinary Officer, Dr Mark Schipp, the avian paramyxo virus has already started killing some hobby birds, and threatens to spread to Victoria's chicken population.He said the affected birds have died suddenly in large numbers and have sometimes appeared tired or have shown neurological signs such as circling or head flicking before death.He added that the bug can also cause conjunctivitis or influenza-like symptoms in humans."The virus causes only mild, short-term conjunctivitis or influenza-like symptoms (in humans)," Australia Associated Press quoted Schipp as reporting on Tuesday."Human infection with this virus is extremely rare and usually occurs only in people who have close direct contact with infected birds."At this stage, there are no reports of the virus causing disease in wild birds, but the Australian Wildlife Health Network has been asked to monitor the situation.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

SUVA, July 25 (Xinhua) -- There are 400,000 people suffering from anaemia in Fiji with a total of population at about 800,000 people, according to the Health Ministry on Monday.Health Minister Doctor Neil Sharma told media that currently 60 per cent of children less than five years old are iron deficient, 40 per cent of women lack iron while 20 per cent of men suffer from iron deficiency in the island nation.Sharma, therefore, called on every family to grow local, eat local and move back to our traditional food habits, telling anaemic, "Do not forget to take your iron tablets."National Advisor Non-Communicable Diseases, Dr Isimeli Tukana also told media on Monday that strategies would include implementing the Food and Health Guidelines for the country in all clinics.All females are supposed to take their iron medication while all pre and primary school children will be given iron supplementation, he added.According to Fiji's Agriculture and Nutrition Department, the island nation, which is in transition towards increasing industrialization, is facing nutritional problems associated with both under-nutrition and over-nutrition.Lack of access to food due to economical shortages is one of the major causes of malnutrition in the country as one quarter of the population is living below the poverty line and most are living in illegal squatter settlements in search of employment and educational opportunities in urban areas.The problem of over-nutrition, on the other hand, may be associated with the change in the consumption patterns towards a diet high in energy but low in fibre, vitamins and minerals and a sedentary lifestyle.

CANBERRA, Aug. 31 (Xinhua) -- Australia's new chief medical officer, Professor Chris Baggoley, on Wednesday said Australian should not be worried about reports that a mutant strain of the deadly bird flu virus is spreading across Asia and beyond.On Monday, the UN's Food and Agriculture Organization (FAO) said a mutant strain of the deadly avian influenza virus was spreading in Asia and issued a warning that the bird flu could spread from poultry to humans. It urged "heightened readiness and surveillance" as the mutant strain posed "unpredictable risks to human health."But Professor Baggoley, who took office on Tuesday, said Australia is well served by strict testing and customs regimes, adding that avian migration patterns also mean infected birds are highly unlikely to arrive in Australia."I don't think we should be worried," Prof Baggoley told Sky News."The country and the Australian government is certainly vigilant in relation to bird flu."Prof. Baggoley insisted the H5N1 virus remains overwhelmingly a disease of birds and it is very uncommon for humans to catch it. It is also exceedingly rare for humans to spread it among themselves.He said that even if bird flu did arrive and affected humans, Australia is ready to respond to any new and significant developments in bird flu."Australia tests migratory wild birds, looking for H5N1, and has been doing this for some years and has never found it," he said."On the human side of things, Australia has been preparing for a possible outbreak of H5N1 since 2004."We've got the laboratory capacity to diagnose influenza; we've got arrangements in place for a rapid production of an H5N1 vaccine for humans, and we've got ready access to antivirals."There have been no outbreaks of bird flu in Australia to date.The UN said the latest human death from bird flu occurred earlier this month in Cambodia, which has registered eight cases of human infection this year, all of them fatal.H5N1 has infected 565 people since it first appeared in 2003, killing 331.

WASHINGTON, Sept. 12 (Xinhua) -- An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, U.S. researchers find.Over the course of four weeks, mice genetically engineered to lack the gene for protein kinase C (PKC) epsilon consumed less of a nicotine-containing water solution than normal mice, and were less likely to return to a chamber in which they had been given nicotine. In contrast, normal mice steadily increased their consumption of nicotine solution while the mice lacking PKC epsilon did not.The study conducted by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco, appeared Monday in the online edition of the Proceedings of the National Academy of Sciences.In normal mice, as in humans, nicotine binds to a certain class of nicotinic receptors located on dopamine neurons, which causes dopamine to be released in the brain. Dopamine creates a feeling of enjoyment, and thus prompts a sense of reward. Researchers found that mice lacking PKC epsilon are deficient in these nicotinic receptors.The finding complements earlier research in which researchers found that mice genetically engineered to lack the PKC epsilon enzyme drank less alcohol than normal mice and were disinclined to return to a chamber in which they had been given alcohol."This could mean that these mice might not get the same sense of reward from nicotine or alcohol," said Gallo senior associate director and investigator Robert Messing. "The enzyme looks like it regulates the part of the reward system that involves these nicotinic receptors."The reward system is a complex of areas in the brain that affect craving for nicotine, alcohol and other addictive substances.The next step in the research, said Messing, would be to develop compounds that inhibit PKC epsilon. The ultimate goal, he added, would be medications that could be used "to take the edge off of addiction by helping people get over some of their reward craving."